StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Harvard Bioscience's total debt was $36.68M at Jun 30, 2026. For fiscal 2025 it was $35.87M, down 2.9% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $57.21M in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$35.87M-2.9%
FY2024Dec 31, 2024$36.96M+0.3%
FY2023Dec 31, 2023$36.84M-21.8%
FY2022Dec 31, 2022$47.10M-3.1%
FY2021Dec 31, 2021$48.61M+0.7%
FY2020Dec 31, 2020$48.29M-3.7%
FY2019Dec 31, 2019$50.12M-12.4%
FY2018Dec 31, 2018$57.21M+536.9%
FY2017Dec 31, 2017$8.98M-21.0%
FY2016Dec 31, 2016$11.37M-30.5%
FY2015Dec 31, 2015$16.37M-0.5%
FY2014Dec 31, 2014$16.45M-16.7%
FY2013Dec 31, 2013$19.75M+52.5%
FY2012Dec 31, 2012$12.95M-20.6%
FY2011Dec 31, 2011$16.30M-9.5%
FY2010Dec 31, 2010$18.01M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$36.68M-4.1%
Q1 FY2026Mar 31, 2026$36.21M+0.7%
Q4 FY2025Dec 31, 2025$35.87M-0.1%
Q4 FY2024Dec 31, 2024$36.96M+0.3%
Q3 FY2024Sep 30, 2024$38.25M-2.0%
Q2 FY2024Jun 30, 2024$35.96M-13.8%
Q1 FY2024Mar 31, 2024$35.89M-19.0%
Q4 FY2023Dec 31, 2023$36.84M-21.8%
Q3 FY2023Sep 30, 2023$39.02M-21.2%
Q2 FY2023Jun 30, 2023$41.70M-14.5%
Q1 FY2023Mar 31, 2023$44.33M-10.0%
Q4 FY2022Dec 31, 2022$47.10M-3.1%
Q3 FY2022Sep 30, 2022$49.53M+8.9%
Q2 FY2022Jun 30, 2022$48.76M+12.3%
Q1 FY2022Mar 31, 2022$49.24M+12.3%
Q4 FY2021Dec 31, 2021$48.61M+0.7%
Q3 FY2021Sep 30, 2021$45.49M+3.7%
Q2 FY2021Jun 30, 2021$43.42M-1.6%
Q1 FY2021Mar 31, 2021$43.85M-11.4%
Q4 FY2020Dec 31, 2020$48.29M-3.7%
Q3 FY2020Sep 30, 2020$43.87M-15.2%
Q2 FY2020Jun 30, 2020$44.12M-15.8%
Q1 FY2020Mar 31, 2020$49.48M-8.6%
Q4 FY2019Dec 31, 2019$50.12M-12.4%
Q3 FY2019Sep 30, 2019$51.71M-12.7%
Q2 FY2019Jun 30, 2019$52.41M-12.4%
Q1 FY2019Mar 31, 2019$54.14M-12.1%
Q4 FY2018Dec 31, 2018$57.21M+536.9%
Q3 FY2018Sep 30, 2018$59.25M+512.4%
Q2 FY2018Jun 30, 2018$59.83M+474.3%
Q1 FY2018Mar 31, 2018$61.57M+463.3%
Q4 FY2017Dec 31, 2017$8.98M-21.0%
Q3 FY2017Sep 30, 2017$9.67M-23.6%
Q2 FY2017Jun 30, 2017$10.42M–
Q1 FY2017Mar 31, 2017$10.93M–
Q4 FY2016Dec 31, 2016$11.37M–
Q3 FY2016Sep 30, 2016$12.67M–

More Harvard Bioscience figures

See a number that looks wrong?